Erica A Golemis Selected Research

Kaposi Sarcoma (Kaposi's Sarcoma)

3/2007	In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors.
12/2003	Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erica A Golemis Research Topics

Disease

76	Neoplasms (Cancer) 04/2022 - 01/2002
13	Neoplasm Metastasis (Metastasis) 04/2022 - 04/2008
7	Squamous Cell Carcinoma of Head and Neck 01/2022 - 08/2009
7	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2020 - 07/2013
6	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2008
6	Cysts 01/2020 - 07/2013
5	Genomic Instability 01/2021 - 01/2004
5	Aneuploidy (Aneuploid) 02/2015 - 01/2004
4	Lung Neoplasms (Lung Cancer) 04/2022 - 04/2010
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 01/2016
4	Adenocarcinoma 10/2020 - 01/2016
4	Carcinoma (Carcinomatosis) 01/2018 - 10/2002
4	Head and Neck Neoplasms (Head and Neck Cancer) 03/2017 - 12/2011
4	Epilepsy (Aura) 06/2011 - 10/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 01/2013
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2019 - 10/2016
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 12/2013
2	Carcinogenesis 01/2021 - 09/2013
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2020 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 12/2015
2	Glioblastoma (Glioblastoma Multiforme) 05/2017 - 04/2010
2	Alzheimer Disease (Alzheimer's Disease) 10/2015 - 01/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2013 - 12/2011
2	Melanoma (Melanoma, Malignant) 04/2010 - 10/2007
2	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2007 - 12/2003
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 01/2020
1	Pathologic Complete Response 01/2020
1	Inflammation (Inflammations) 01/2020
1	Malignant Pleural Effusion 06/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Ascites 01/2018

Drug/Important Bio-Agent (IBA)

50	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2002
11	Aurora Kinase AIBA 08/2020 - 09/2010
9	Pharmaceutical PreparationsIBA 01/2021 - 10/2007
8	Phosphotransferases (Kinase)IBA 01/2021 - 06/2007
8	Biomarkers (Surrogate Marker)IBA 11/2017 - 09/2009
7	Biological ProductsIBA 11/2020 - 08/2009
7	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 11/2015
6	ErbB Receptors (EGF Receptor)IBA 03/2021 - 09/2010
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2013
4	Messenger RNA (mRNA)IBA 01/2018 - 04/2008
4	Small Interfering RNA (siRNA)IBA 01/2017 - 09/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 09/2013 - 03/2007
3	STA 9090IBA 01/2021 - 09/2013
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021 - 01/2014
3	CholesterolIBA 10/2020 - 01/2013
3	MLN 8237IBA 09/2019 - 01/2015
3	Cytotoxins (Cytolysins)IBA 03/2017 - 09/2010
3	STA-12-8666IBA 01/2017 - 10/2016
3	Aurora KinasesIBA 09/2013 - 10/2005
2	Oxidoreductases (Dehydrogenase)IBA 04/2022 - 01/2013
2	EnzymesIBA 04/2022 - 10/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2019
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2021 - 05/2017
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 08/2009
2	TRPP Cation ChannelsIBA 01/2020 - 01/2018
2	Estrogen ReceptorsIBA 01/2020 - 01/2017
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2017
2	p21-Activated KinasesIBA 09/2019 - 12/2003
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 10/2002
2	Cadherins (E-Cadherin)IBA 01/2018 - 01/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 10/2016
2	Drug CombinationsIBA 10/2016 - 09/2013
2	Cyclin DIBA 01/2016 - 08/2015
2	SterolsIBA 09/2015 - 01/2013
2	Dasatinib (BMS 354825)FDA Link 01/2015 - 11/2010
2	STA-2842IBA 01/2014 - 07/2013
2	AntibodiesIBA 12/2013 - 12/2011
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 06/2011 - 09/2010
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2011 - 01/2004
1	GlyceraldehydeIBA 04/2022
1	PhosphofructokinasesIBA 04/2022
1	Phosphates (Orthophosphate)IBA 04/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	DNA Primase (Primase)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	ChromatinIBA 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	src-Family KinasesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	ras ProteinsIBA 01/2020
1	LigandsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 09/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2019
1	Sclerosing Solutions (Sclerosing Agents)IBA 06/2019
1	adavosertibIBA 01/2019
1	Sunitinib (Sutent)FDA Link 01/2019
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2018

Therapy/Procedure

26	Therapeutics 01/2022 - 12/2007
5	Drug Therapy (Chemotherapy) 01/2020 - 11/2010
2	Neoadjuvant Therapy 01/2020 - 12/2015
2	Cystectomy 01/2020 - 12/2015
1	Secondary Prevention 01/2018